BNBX vs RJF · P/E 0.0, rev $2.2M vs rev $15.91B
Applied DNA Sciences, Inc. (BNBX) versus RJF (RJF) — a side-by-side from cached financials, not a winner call.
Applied DNA Sciences, Inc. (BNBX) is a asset management company listed on NASDAQ.
RJF (RJF) common stock.
Latest reported BNBX revenue for 2026-06-30 was $2.2M. Net income was -$29.9M. Revenue was up 38.1% from 2026-03-31 to 2026-06-30. BNBX currently screens at market cap $3.3M and trailing P/E 0.0.
Latest reported RJF revenue for 2025-09-30 was $15.91B. Net income was $2.13B. Revenue was up 6.6% from 2024-09-30 to 2025-09-30. RJF currently screens at market cap $0.
BNBX currently screens at market cap $3.3M and trailing P/E 0.0. RJF currently screens at market cap $0.
Not investment advice. Open the BNBX and RJF stock pages for the full models.
Not investment advice.